Skip to content

Baxter International BAX Americas — Net Sales

Discontinued — last reported Q2 '23

Similar metrics at other companies

Molson Coors Beverage Company logo
TAPAmericas — Net Sales
$1.9B+1.0%
Vertiv Holdings Co logo
VRTAmericas — Net Sales
$1.82B+52.2%
Flex Ltd. logo
FLEXAmericas — Net Sales
$3.46B+9.2%
Sanmina Corp logo
SANMAmericas — Net Sales
$3.09B+168%
Bio-Rad Laboratories logo
BIOAmericas — Net Sales
$45.1M+13.3%
3M logo
MMMAmericas — Net Sales
$3.15B-1.7%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Baxter International’s 10-Q, filed July 27, 2023, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's americas — net sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's americas — net sales?
Baxter International (BAX) reported americas — net sales of $1.56B in Q2 2023.
How has Baxter International's americas — net sales changed year-over-year?
Baxter International's americas — net sales increased by 4.7% year-over-year, from $1.49B to $1.56B.
What does americas — net sales mean?
Represents the total revenue generated from the sale of medical products and services within the Americas geographic region. This metric reflects the market demand and commercial performance of the company's portfolio in North and South American markets.